Boston Research & Management Inc Vaneck ETF Tr Biotech ETF Transaction History

Boston Research & Management Inc

$407 Million
Q4 2024

A detailed history of Boston Research & Management Inc transactions in Vaneck ETF Tr Biotech ETF stock. As of the latest transaction made, Boston Research & Management Inc holds 11,681 shares of BBH stock, worth $1.92 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

11,681

Previous 11,681 -0.0%

Holding current value

$1.92 Million

Previous $2.07 Million 11.53%

% of portfolio

0.45%

Previous 0.49%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$167.06 - $182.72 $111,930 - $122,422	-670 Reduced 5.42%	11,681 $2.07 Million
Q2 2024 Aug 13, 2024	SELL	$151.99 - $172.48 $56,236 - $63,817	-370 Reduced 2.91%	12,351 $2.08 Million
Q1 2023 May 10, 2023	SELL	$151.32 - $169.5 $6,052 - $6,780	-40 Reduced 0.31%	12,721 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$136.76 - $163.51 $38,292 - $45,782	280 Added 2.24%	12,761 $1.8 Million
Q1 2022 May 12, 2022	SELL	$148.02 - $186.49 $127,889 - $161,127	-864 Reduced 6.47%	12,481 $2.02 Million
Q4 2021 Feb 10, 2022	BUY	$182.1 - $202.87 $9,105 - $10,143	50 Added 0.38%	13,345 $2.53 Million
Q3 2021 Nov 10, 2021	SELL	$195.25 - $220.75 $74,195 - $83,885	-380 Reduced 2.78%	13,295 $2.69 Million
Q3 2021 Nov 10, 2021	BUY	$195.25 - $220.75 $74,195 - $83,885	380 Added 2.86%	13,675 $2.4 Million
Q2 2021 Aug 11, 2021	SELL	$173.72 - $201.85 $66,013 - $76,703	-380 Reduced 2.78%	13,295 $2.68 Million
Q1 2021 May 11, 2021	SELL	$167.43 - $195.8 $35,160 - $41,118	-210 Reduced 1.51%	13,675 $2.4 Million
Q4 2020 Feb 09, 2021	SELL	$152.3 - $177.17 $7,615 - $8,858	-50 Reduced 0.36%	13,885 $2.36 Million
Q3 2020 Nov 09, 2020	SELL	$150.86 - $177.04 $40,581 - $47,623	-269 Reduced 1.89%	13,935 $2.26 Million
Q2 2020 Aug 10, 2020	SELL	$124.43 - $164.89 $29,738 - $39,408	-239 Reduced 1.65%	14,204 $2.31 Million
Q1 2020 May 08, 2020	BUY	$114.53 - $144.75 $34,129 - $43,135	298 Added 2.11%	14,443 $1.85 Million
Q4 2019 Feb 07, 2020	SELL	$114.81 - $142.85 $66,360 - $82,567	-578 Reduced 3.93%	14,145 $1.97 Million
Q3 2019 Nov 12, 2019	SELL	$117.33 - $123.7 $12,906 - $13,607	-110 Reduced 0.74%	14,723 $1.74 Million
Q2 2019 Aug 07, 2019	SELL	N/A	-160 Reduced 1.07%	14,833 $1.91 Million
Q1 2019 May 07, 2019	SELL	N/A	-230 Reduced 1.51%	14,993 $1.93 Million
Q4 2018 Feb 06, 2019	BUY	N/A	4,045 Added 36.19%	15,223 $1.69 Million
Q3 2018 Nov 13, 2018	SELL	N/A	-755 Reduced 6.33%	11,178 $1.52 Million
Q2 2018 Jul 30, 2018	SELL	N/A	-2,670 Reduced 18.28%	11,933 $1.43 Million
Q1 2018 May 09, 2018	SELL	N/A	-2,510 Reduced 14.67%	14,603 $1.76 Million
Q4 2017 Feb 09, 2018	SELL	N/A	-4,875 Reduced 22.17%	17,113 $2.13 Million
Q3 2017 Nov 09, 2017	BUY	N/A	21,988	21,988 $2.95 Million

Others Institutions Holding BBH

# of Institutions

125

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About VANECK ETF TR BIOTECH ETF

Ticker BBH
Sector ETFs
Industry ETFs

More about BBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Account

Boston Research & Management Inc Vaneck ETF Tr Biotech ETF Transaction History